These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3209718)

  • 1. Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study.
    Fyer AJ; Liebowitz MR; Gorman JM; Campeas R; Levin A; Sandberg D; Fyer M; Hollander E; Papp L; Goetz D
    J Clin Psychopharmacol; 1988 Aug; 8(4):270-4. PubMed ID: 3209718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
    DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
    J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC; Swinson RP
    Psychopharmacol Bull; 1986; 22(1):173-6. PubMed ID: 3726063
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment.
    Nardi AE; Freire RC; Valença AM; Amrein R; de Cerqueira AC; Lopes FL; Nascimento I; Mezzasalma MA; Veras AB; Sardinha A; de Carvalho MR; da Costa RT; Levitan MN; de-Melo-Neto VL; Soares-Filho GL; Versiani M
    J Clin Psychopharmacol; 2010 Jun; 30(3):290-3. PubMed ID: 20473065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
    Risse SC; Whitters A; Burke J; Chen S; Scurfield RM; Raskind MA
    J Clin Psychiatry; 1990 May; 51(5):206-9. PubMed ID: 2335496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
    Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of alprazolam treatment in panic patients.
    Fyer AJ; Liebowitz MR; Gorman JM; Campeas R; Levin A; Davies SO; Goetz D; Klein DF
    Am J Psychiatry; 1987 Mar; 144(3):303-8. PubMed ID: 3826428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of panic disorder and agoraphobia with clonazepam.
    Spier SA; Tesar GE; Rosenbaum JF; Woods SW
    J Clin Psychiatry; 1986 May; 47(5):238-42. PubMed ID: 3700341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
    Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
    J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprazolam withdrawal symptoms in agoraphobia with panic disorder: observations from a controlled Anglo-Canadian study.
    O'Sullivan GH; Swinson R; Kuch K; Marks IM; Basoglu M; Noshirvani H
    J Psychopharmacol; 1996 Jan; 10(2):101-9. PubMed ID: 22302886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from alprazolam dependency using clonazepam: clinical observations.
    Patterson JF
    J Clin Psychiatry; 1990 May; 51 Suppl():47-9; discussion 50-3. PubMed ID: 2335501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.